Nephro-Urology Monthly

Published by: Kowsar

Monitoring Cyclosporine Absorption: A Step Beyond Therapeutic Drug Monitoring

Po-Chang Lee 1 , *
Author Information
1 National Cheng Kung University Hospital, Taipei, Taiwan
Article information
  • Nephro-Urology Monthly: December 01, 2012, 5 (1); 712-713
  • Published Online: December 15, 2012
  • Article Type: Letter
  • Received: July 27, 2012
  • Accepted: July 30, 2012
  • DOI: 10.5812/numonthly.7463

To Cite: Lee P. Monitoring Cyclosporine Absorption: A Step Beyond Therapeutic Drug Monitoring, Nephro-Urol Mon. 2012 ; 5(1):712-713. doi: 10.5812/numonthly.7463.

Copyright © 2012, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Einollahi B, Teimoori M, Rostami Z. Change of cyclosporine absorption over the time after kidney transplantation. Nephro-Urol Mon. 2012; 4(2): 470-4[DOI]
  • 2. Moyer TP, Johnson P, Faynor SM, Sterioff S. Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems. Clin Biochem. 1986; 19(2): 83-9[DOI][PubMed]
  • 3. Lee PC, Chang SS, Shieh SC, Wu ZC, Wang WM, Wang JD, et al. Cyclosporine or tacrolimus: which is the better partner for myfortic or cellcept? Transplant Proc. 2012; 44(1): 137-9[DOI][PubMed]
  • 4. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005; 16(10): 3015-26[DOI][PubMed]
  • 5. Vanrenterghem YF. Tailoring immunosuppressive therapy for renal transplant recipients. Pediatr Transplant. 2001; 5(6): 467-72[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments